• 1277 Citations
  • 19 h-Index
20042020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Teiji Kuzuya is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 19 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 1277 Citations
  • 19 h-Index
  • 94 Article
  • 2 Letter
  • 1 Short survey
  • 1 Review article

Complete response of advanced hepatocellular carcinoma achieved by sorafenib dose re-escalation after failure of long-term low-dose-sorafenib treatment combined with transcatheter arterial chemoembolization: a case report

Muto, H., Kuzuya, T., Ito, T., Ishizu, Y., Honda, T., Ishikawa, T., Ishigami, M. & Fujishiro, M., 01-06-2020, In : Clinical Journal of Gastroenterology. 13, 3, p. 397-402 6 p.

Research output: Contribution to journalArticle

  • Correlation of serum zinc levels with pathological and laboratory findings in patients with nonalcoholic fatty liver disease

    Ito, T., Ishigami, M., Ishizu, Y., Kuzuya, T., Honda, T., Ishikawa, T., Toyoda, H., Kumada, T. & Fujishiro, M., 2020, (Accepted/In press) In : European Journal of Gastroenterology and Hepatology. p. 748-753 6 p.

    Research output: Contribution to journalArticle

  • 1 Citation (Scopus)

    Effect of weight change and lifestyle modifications on the development or remission of nonalcoholic fatty liver disease: sex-specific analysis

    Yoshioka, N., Ishigami, M., Watanabe, Y., Sumi, H., Doisaki, M., Yamaguchi, T., Ito, T., Ishizu, Y., Kuzuya, T., Honda, T., Ishikawa, T., Haruta, J. I. & Fujishiro, M., 01-12-2020, In : Scientific reports. 10, 1, 481.

    Research output: Contribution to journalArticle

    Open Access
  • Efficacy and Safety of Sorafenib in Unresectable Hepatocellular Carcinoma with Bile Duct Invasion

    Tanaka, T., Kuzuya, T., Ishigami, M., Ito, T., Ishizu, Y., Honda, T., Ishikawa, T. & Fujishiro, M., 2020, (Accepted/In press) In : Oncology (Switzerland).

    Research output: Contribution to journalArticle

  • Favorable radiological antitumor response at 2 weeks after starting lenvatinib for patients with advanced hepatocellular carcinoma

    Kuzuya, T., Ishigami, M., Ito, T., Ishizu, Y., Honda, T., Ishikawa, T. & Fujishiro, M., 01-03-2020, In : Hepatology Research. 50, 3, p. 374-381 8 p.

    Research output: Contribution to journalArticle

  • 6 Citations (Scopus)